The phylogeny of yellow fever virus 17D vaccines

被引:25
作者
Stock, Nina K. [1 ]
Boschetti, Nicola [2 ]
Herzog, Christian [2 ]
Appelhans, Marc S. [3 ]
Niedrig, Matthias [1 ]
机构
[1] Robert Koch Inst, D-13353 Berlin, Germany
[2] Crucell Switzerland AG, CH-3018 Bern, Switzerland
[3] Leiden Univ, Netherlands Ctr Biodivers Nat, Sect NHN, NL-2300 RA Leiden, Netherlands
关键词
Yellow fever; 17D; Vaccine; Phylogeny; Full genome; NUCLEOTIDE-SEQUENCE; VISCEROTROPIC DISEASE; IMMUNOGENICITY; SAFETY; STRAIN;
D O I
10.1016/j.vaccine.2011.12.057
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
In recent years the safety of the yellow fever live vaccine 17D came under scrutiny. The focus was on serious adverse events after vaccinations that resemble a wild type infection with yellow fever and whose reasons are still not known. Also the exact mechanism of attenuation of the vaccine remains unknown to this day. In this context, the standards of safety and surveillance in vaccine production and administration have been discussed. Therein embodied was the demand for improved documentation of the derivation of the seed virus used for yellow fever vaccine production. So far, there was just a historical genealogy available that is based on source area and passage level. However, there is a need for a documentation based on molecular information to get better insights into the mechanisms of pathology. In this work we sequenced the whole genome of different passages of the YFV-17D strain used by Crucell Switzerland AG for vaccine production. Using all other publically available 17D full genome sequences we compared the sequence variance of all vaccine strains and oppose a phylogenetic tree based on full genome sequences to the historical genealogy. (C) 2011 Elsevier Ltd. All rights reserved.
引用
收藏
页码:989 / 994
页数:6
相关论文
共 23 条
[1]  
Alan D, 2009, VACCINES BIODEFENSE
[2]  
Bae H-G, 2006, ANAL IMMUNANTWORT NA
[3]   High stability of yellow fever 17D-204 vaccine:: A 12-year restrospective analysis of large-scale production [J].
Barban, V. ;
Girerd, Y. ;
Aguirre, A. ;
Gulia, S. ;
Petiard, F. ;
Riou, P. ;
Barrere, B. ;
Lang, J. .
VACCINE, 2007, 25 (15) :2941-2950
[4]   17D yellow fever vaccines: New insights - A report of a workshop held during the World Congress on Medicine and Health in the Tropics, Marseille, France, Monday 12 September 2005 [J].
Barrett, Alan D. T. ;
Monath, Thomas P. ;
Barban, Veronique ;
Niedrig, Matthias ;
Teuwen, Dirk E. .
VACCINE, 2007, 25 (15) :2758-2765
[5]   Yellow fever vaccine - how does it work and why do rare cases of serious adverse events take place? [J].
Barrett, Alan D. T. ;
Teuwen, Dirk E. .
CURRENT OPINION IN IMMUNOLOGY, 2009, 21 (03) :308-313
[6]   Yellow fever vaccine-associated viscerotropic disease and death in Spain [J].
Doblas, A. ;
Domingo, C. ;
Bae, H. G. ;
Bohórquez, C. L. ;
de Ory, F. ;
Niedrig, M. ;
Mora, D. ;
Carrasco, F. J. ;
Tenorio, A. .
JOURNAL OF CLINICAL VIROLOGY, 2006, 36 (02) :156-158
[7]  
DOSSANTOS CND, 1995, VIRUS RES, V35, P35
[8]   NUCLEOTIDE-SEQUENCE COMPARISON OF THE GENOME OF 2 17D-204 YELLOW-FEVER VACCINES [J].
DUPUY, A ;
DESPRES, P ;
CAHOUR, A ;
GIRARD, M ;
BOULOY, M .
NUCLEIC ACIDS RESEARCH, 1989, 17 (10) :3989-3989
[9]  
Ferguson Morag, 2010, Vaccine, V28, P8236, DOI 10.1016/j.vaccine.2010.10.070
[10]  
Frierson J. Gordon, 2010, Yale Journal of Biology and Medicine, V83, P77